Emerging Lisinopril Market Outlook Trend 2025-2034:

How Is the Lisinopril Market Projected to Grow, and What Is Its Market Size?
The market size for Lisinopril has seen a robust growth in the past few years. It is projected to increase from $1.76 billion in 2024 to $1.88 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.7%. This progress in the historical timeframe can be credited to factors such as improved accessibility, alterations in lifestyle, enhancement in screening programs, wider availability of generic Lisinopril, and enhanced patient compliance.

Expectations are high for robust expansion in the lisinopril market over the coming years. The predicted value to reach in 2029 is $2.4 billion, forecasting a compound annual growth rate (CAGR) of 6.3%. This projected growth can be linked to a rise in cases of hypertension and cardiovascular ailments, the introduction of generic versions and their cost-effective nature, increasing public awareness and early detection, a growing demand for effective medical interventions, and an aging demographic. Notable trends within the forecast period encompass advancements in medication delivery, necessity for improved and patient-customized medication delivery methods, preference for cost-efficient solutions, increasing need for effective heart failure treatments, and a high demand for practical interventions for diabetic kidney diseases.

What Is Driving the Growth Trajectory of the Lisinopril Market?
The escalating rates of cardiovascular diseases are predicted to fuel the expansion of the lisinopril market. Cardiovascular diseases (CVDs), which encompasses various disorders affecting the heart and blood vessels, are becoming increasingly commonplace due to factors such as population growth, ageing, risk factors and non-implementation of proven prevention and control strategies. Lisinopril plays a vital role in managing such diseases mainly by reducing blood pressure along with relieving the stress on the heart and kidneys. By preventing the production of angiotensin II, lisinopril aids in blood vessel dilation, blood volume reduction and safeguarding organs from harm. For instance, as per data from the Singapore Heart Foundation (SHF), a non-profit organization in Singapore, ischemic heart diseases had caused 5,302 deaths in May 2024, slightly up from 5,290 deaths in 2022. Thus, the growing prevalence of cardiovascular diseases is acting a catalyst for the growth in the lisinopril market. Moving onto the other factor driving the lisinopril market growth, it is the expanding prevalence of hypertension. Hypertension, also known as high blood pressure, is a medical condition characterized by consistently high force exerted by blood against the artery walls. Rising instances of hypertension can be traced back to an unhealthy diet, inactive lifestyle, ageing population, and prolonged stress. Lisinopril proves to be an effective medication for managing hypertension by inhibiting the production of angiotensin II, leading to a relaxed state of the blood vessels, decreased blood volume, and thereby lower blood pressure. To illustrate, in March 2023, the World Health Organization, a health organization based in Switzerland, reported that globally, around 1.28 billion adults aged between 30-79 years were suffering from hypertension. Hence, the escalating rates of hypertension are set to boost the lisinopril market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp

Who Are the Major Industry Players Fueling Lisinopril Market Expansion?
Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited, Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences

Which Key Developments Are Influencing the Lisinopril Market?

How Is the Segmentation of the Lisinopril Market Defined?
The lisinopril market covered in this report is segmented -

1) By Brand: Zestoretic, Prinivil, Zestril, Other Brands
2) By Disease: Hypertension, Heart Failure, Heart Attack, Strokes, Diabetic Kidney Disease, Other Diseases
3) By Dosage: Tablet, Liquid, Other Dosages
4) By Population Type: Children, Adults
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Zestoretic: Different Dosage Forms, Generic Versions Of Zestoretic
2) By Prinivil: Different Dosage Forms, Generic Versions Of Prinivil
3) By Zestril: Different Dosage Forms, Generic Versions Of Zestril
4) By Other Brands: International Brand Variants, Combination Drug Formulations

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

What Is the Leading Region in the Lisinopril Market?
North America was the largest region in the lisinopril market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Lisinopril Global Market Report?

- Market Size Analysis: Analyze the Lisinopril Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Lisinopril Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Lisinopril Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Lisinopril Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16465

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.